Yangyang Yu

5.8k total citations · 2 hit papers
68 papers, 4.4k citations indexed

About

Yangyang Yu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yangyang Yu has authored 68 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 12 papers in Oncology. Recurrent topics in Yangyang Yu's work include Mast cells and histamine (9 papers), Asthma and respiratory diseases (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Yangyang Yu is often cited by papers focused on Mast cells and histamine (9 papers), Asthma and respiratory diseases (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Yangyang Yu collaborates with scholars based in China, Hong Kong and United States. Yangyang Yu's co-authors include Xinxin Song, Jia Huang, Daolin Tang, Yang Xie, Xin Sun, Wen‐Chi Hou, Rui Kang, Wenwen Chen, Meiling Jin and Shiyou Li and has published in prestigious journals such as Nucleic Acids Research, Advanced Materials and Journal of Clinical Oncology.

In The Last Decade

Yangyang Yu

67 papers receiving 4.4k citations

Hit Papers

Ferroptosis: process and ... 2016 2026 2019 2022 2016 2021 500 1000 1.5k 2.0k 2.5k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Yangyang Yu 2.5k 2.2k 1.6k 503 479 68 4.4k
Rohitha Sriramaratnam 3.6k 1.5× 3.8k 1.8× 2.6k 1.7× 430 0.9× 648 1.4× 9 5.7k
Jiajun Zhu 3.7k 1.5× 1.9k 0.9× 2.3k 1.5× 483 1.0× 786 1.6× 30 5.7k
Boryana Petrova 2.0k 0.8× 1.1k 0.5× 1.1k 0.7× 390 0.8× 504 1.1× 31 4.0k
Naama Kanarek 2.6k 1.1× 1.2k 0.6× 1.6k 1.0× 620 1.2× 766 1.6× 28 5.0k
Jiao Wu 2.6k 1.0× 1.9k 0.9× 1.7k 1.1× 470 0.9× 541 1.1× 98 4.2k
Ryan D. Spangler 1.6k 0.6× 1.1k 0.5× 1.0k 0.7× 346 0.7× 426 0.9× 7 3.3k
John K. Eaton 3.3k 1.3× 3.0k 1.4× 2.5k 1.6× 487 1.0× 825 1.7× 9 5.8k
Yang Xie 2.0k 0.8× 1.9k 0.9× 1.4k 0.9× 251 0.5× 427 0.9× 25 3.3k
Jordan Rossen 1.8k 0.7× 1.3k 0.6× 1.1k 0.7× 368 0.7× 584 1.2× 5 3.7k

Countries citing papers authored by Yangyang Yu

Since Specialization
Citations

This map shows the geographic impact of Yangyang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangyang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangyang Yu more than expected).

Fields of papers citing papers by Yangyang Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangyang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangyang Yu. The network helps show where Yangyang Yu may publish in the future.

Co-authorship network of co-authors of Yangyang Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Yangyang Yu. A scholar is included among the top collaborators of Yangyang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangyang Yu. Yangyang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Yangyang, Ying Wang, Jing Zhang, et al.. (2025). Anaerobic probiotics-in situ Se nanoradiosensitizers selectively anchor to tumor with immuno-regulations for robust cancer radio-immunotherapy. Biomaterials. 318. 123117–123117. 1 indexed citations
2.
Yu, Yangyang, Hongyong Fu, Haifeng Du, et al.. (2024). Overview of research on the application of medicine food homologous bioactive ingredients to functional constipation. SHILAP Revista de lepidopterología. 2(4). 9420057–9420057. 3 indexed citations
3.
Bai, Mingzhou, Sanjie Jiang, Shanshan Chu, et al.. (2024). The telomere-to-telomere (T2T) genome of Peucedanum praeruptorum Dunn provides insights into the genome evolution and coumarin biosynthesis. GigaScience. 13. 7 indexed citations
4.
Zhang, Jiaxin, Tingting Wei, Di Min, et al.. (2024). Deciphering unique enzymatic pathways in sulfonamide biotransformation by direct ammonia oxidizer Alcaligenes ammonioxydans HO-1. Water Research. 273. 123045–123045. 2 indexed citations
5.
Xiao, Lan, et al.. (2023). The Effects of Probiotic Lactobacillus rhamnosus GG on Fecal Flora and Serum Markers of Renal Injury in Mice with Chronic Kidney Disease. Frontiers in Bioscience-Landmark. 28(9). 226–226. 6 indexed citations
7.
Chen, Chuan’ai, Dekun Wang, Yangyang Yu, et al.. (2021). Legumain promotes tubular ferroptosis by facilitating chaperone-mediated autophagy of GPX4 in AKI. Cell Death and Disease. 12(1). 65–65. 233 indexed citations breakdown →
8.
Shen, Wenbin, Boer Shan, Shanhui Liang, et al.. (2021). Hybrid Capture-based Genomic Profiling of Circulating Tumor DNA From Patients With Advanced Ovarian Cancer. Pathology & Oncology Research. 27. 581534–581534. 7 indexed citations
9.
Yu, Yangyang, et al.. (2020). PKMYT1 as a Potential Target to Improve the Radiosensitivity of Lung Adenocarcinoma. Frontiers in Genetics. 11. 376–376. 29 indexed citations
10.
Qiao, Jie, Jinping Zhao, Jianfeng Dong, et al.. (2019). MicroRNA-153 improves the neurogenesis of neural stem cells and enhances the cognitive ability of aged mice through the notch signaling pathway. Cell Death and Differentiation. 27(2). 808–825. 48 indexed citations
12.
Wang, Shifeng, Yuxin Zhang, Qiao Zhang, et al.. (2017). Content decline of SERCA inhibitors saikosaponin a and d attenuates cardiotoxicity and hepatotoxicity of vinegar-baked Radix bupleuri. Environmental Toxicology and Pharmacology. 52. 129–137. 19 indexed citations
13.
Wang, Yu, Shengnan Sun, Qing Liu, et al.. (2016). Autocrine Complement Inhibits IL10-Dependent T-cell–Mediated Antitumor Immunity to Promote Tumor Progression. Cancer Discovery. 6(9). 1022–1035. 122 indexed citations
14.
Chen, Xiaofan, Zhang Zhang, Xia Dou, et al.. (2016). Histamine H4 Receptor mediates interleukin-8 and TNF-α release in human mast cells via multiple signaling pathways.. PubMed. 62(1). 84–9. 18 indexed citations
15.
Wei, Tingyi, Wenwen Jia, Zhen Qian, et al.. (2016). Folic Acid Supports Pluripotency and Reprogramming by Regulating LIF/STAT3 and MAPK/ERK Signaling. Stem Cells and Development. 26(1). 49–59. 13 indexed citations
16.
Yu, Yangyang, Zhuo Mao, Meiling Jin, et al.. (2016). Go is required for the release of IL-8 and TNF-α, but not degranulation in human mast cells. European Journal of Pharmacology. 780. 115–121. 9 indexed citations
17.
Xu, Zhenyu, Jing Shen, Maggie Haitian Wang, et al.. (2016). Comprehensive molecular profiling of the B7 family of immune-regulatory ligands in breast cancer. OncoImmunology. 5(8). e1207841–e1207841. 36 indexed citations
18.
Wei, Ting, Wei Chen, Lingling Wang, et al.. (2015). An HDAC2-TET1 switch at distinct chromatin regions significantly promotes the maturation of pre-iPS to iPS cells. Nucleic Acids Research. 43(11). 5409–5422. 22 indexed citations
19.
Huang, Danping, et al.. (2009). Histological and ultrastructural study on the medial canthal ligament of blepharophimosis, ptosis and epicanthus inversus syndrome. Chinese Medical Journal. 122(22). 2700–2704. 2 indexed citations
20.
Han, Hui, Yangyang Yu, & Yuhong Wang. (2008). Imatinib mesylate–induced repigmentation of vitiligo lesions in a patient with recurrent gastrointestinal stromal tumors. Journal of the American Academy of Dermatology. 59(5). S80–S83. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026